NSD3 and cancer: Additionally, several NSD3 missense mutations, such as E1181K and T1232A, have been proposed to enhance the growth of cancer cells and xenograft tumors, through disruption of an auto‐inhibitory loop within the NSD3 protein product so as to augment its enzymatic function.19, 49